The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADTALEM GLOBAL ED INC COM 00737L103 47,278 1,318,776 SH   SOLE   1,318,776 0 0
ALPHABET INC CAP STK CL A 02079K305 503 517 SH   SOLE   517 0 0
ALPHABET INC CAP STK CL C 02079K107 7,463 7,781 SH   SOLE   7,781 0 0
AMGEN COM 031162100 203 1,090 SH   SOLE   1,090 0 0
BAIDU INC SPON ADR REP A 056752108 743 3,000 SH   SOLE   3,000 0 0
BERKSHIRE HATHAWAY INC DEL CL A 084670108 275 1 SH   SOLE   1 0 0
BERKSHIRE HATHAWAY INC DEL CL B 084670702 875 4,773 SH   SOLE   4,773 0 0
CTRIP COM INTL LTD AMERICAN DEP SHS 22943F100 2,114 40,092 SH   SOLE   40,092 0 0
MARKEL CORP COM 570535104 246 230 SH   SOLE   230 0 0
MASTERCARD INC CL A 57636Q104 24,389 172,726 SH   SOLE   172,726 0 0
PRAXAIR INC COM 74005P104 434 3,107 SH   SOLE   3,107 0 0
PRICELINE GRP INC COM NEW 741503403 798 436 SH   SOLE   436 0 0
VALEANT PHARMACEUTICALS INTL COM 91911K102 3,900 272,148 SH   SOLE   272,148 0 0
VALEANT PHARMACEUTICALS INTL CALL 91911K902 244 17,000 SH   SOLE   17,000 0 0